Objective: To evaluate the utility of liquid-based cytology in detecting recurrent cervical cancer among treated cervical cancer patients.
Methods: A retrospective multi-institution study identified patients treated for cervical cancer from January 1, 2000, to November 1, 2009, through local cancer registries and patient databases. Patients were excluded if they lacked follow-up or treatment data.
In the roundtable that follows, clinicians discuss a study published in this issue of the Journal in light of its methodology, relevance to practice, and implications for future research.
View Article and Find Full Text PDF